These clonotypes were also associated with upregulation of a transendothelial migration signature as well as the pro-inflammatory chemokine receptor CX3CR1. Our data suggest that the fractalkine receptor CX3CR1-expressing CD8+ Teff cells circulate in blood and may serve as a reservoir to replenish T cells within the tumor. The gene discussed is CD8A; the disease is neoplasm.